Association Between Psychiatric Symptoms and Craving in Drug Withdrawal

Wang, Mu; Chen, Yanyan; Li, Huazhi; Zhang, Xiaoyu; Xu, Yubing; Ding, Zenghui; Ma, Zuchang; Sun, Yining

doi:10.1007/s11469-022-00783-4

Cited by 2 publications

(5 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Psychiatric symptoms and/or psychopathological behaviors are not only related to the development of a SUD; in fact, authors have found significant correlations between some psychiatric symptoms and various phases of drug addiction, e.g., abstinence [13] or craving [14].…”

Section: Comorbidity With Psychiatric Symptomsmentioning

confidence: 99%

“…A positive association was found between anxiety, depression, and craving intensity. In addition, time of abstinence could influence the association between craving and psychiatric symptoms [13].…”

Section: Complex Entanglement: Substance Use Disorder; Personality; A...mentioning

confidence: 99%

“…Anxiety disorders are frequently found in patients diagnosed with substance use disorder (SUD) [31,36], and research also shows a strong correlation with craving intensity [13]. Anxiety symptoms reveal a strong association with substance use and addiction severity [30].…”

Section: Anxiety and Addictionmentioning

confidence: 99%

Section: Mood Disorders and Addictionmentioning

confidence: 99%

“…Mood disorders are commonly found in comorbidity both with SUD [31,36] and craving intensity [13]. In particular, depression was proved to have a positive correlation with craving intensity for heroin in patients receiving methadone maintenance treatment [13]. Interestingly, although substance use may impair brain function and cause depressive or anxiety symptoms, people may use substances more frequently as a form of "selfmedication" to manage such symptoms [30].…”

Section: Mood Disorders and Addictionmentioning

confidence: 99%

See 4 more Smart Citations

A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes

Belfiore,

Galofaro,

Cotroneo

et al. 2024

Psychoactives

View full text Add to dashboard Cite

We explored the intricate interplay of biological, social, and psychological factors contributing to substance use disorder (SUD) and co-occurring psychiatric symptoms. Drug misuse is a global concern, with increasing prevalence rates affecting mental well-being and safety. The spectrum of SUD includes polysubstance users, posing challenges for treatment and associated health outcomes. Various psychoactive substances like cannabis, hallucinogens, opioids, and stimulants impact addiction vulnerability, with marijuana being widely used globally. Gender differences in SUD prevalence have narrowed, with women escalating drug consumption rapidly once initiated. Age disparities in substance use highlight regional variations among adolescents. Comorbidities with psychiatric symptoms are common, with mood and anxiety disorders frequently observed. This study aimed to analyze factors influencing SUD development and maintenance to inform prevention strategies and treatment recommendations. By conducting a systematic search of databases, sixty articles were reviewed, revealing diverse methodologies and geographic locations. Biological factors, including neurotransmitter systems like endocannabinoid and dopaminergic systems, play a significant role in addiction. Genetic and neurobiological factors contribute to cannabis addiction susceptibility. Social factors such as childhood experiences and parenting styles influence substance use behaviors. Psychological factors like personality traits and mental health conditions interact with SUD development. Understanding these multifaceted interactions is crucial for designing effective interventions to address the complexities of SUD and co-occurring psychiatric symptoms.

show abstract

Section: Comorbidity With Psychiatric Symptomsmentioning

confidence: 99%

Section: Complex Entanglement: Substance Use Disorder; Personality; A...mentioning

confidence: 99%